1 unchanged sentence
Our common stock currently is traded on the NASDAQ Stock Market LLC.
−Removed: As of March 27, 2020 , we had approximately 600 stockholders of record.
−Removed: Since many stockholders choose to hold their shares under the name of their brokerage firm, we estimate that the actual number of stockholders was over 3,500 shareholders.
+Added: As of March 29, 2021, we had approxim ately 600 stockholders of record.
+Added: Since many stockholders choose to hold their shares under the name of their brokerage firm, we estimate that the ac tual number of stockholders was over 3,500 stockholders.
Securities Authorized for Issuance Under Equity Compensation Plans
Number of Securities to be Issued Upon Exercise of Outstanding Options, Warrants and Rights
−Removed: Weighted Average Exercise Price of Outstanding Options, Warrants and Rights
−Removed: Number of Securities Remaining Available for Future Issuance Under Equity Compensation Plans (excluding securities reflected in column (a))
+Added: (a) Weighted Average Exercise Price of Outstanding Options, Warrants and Rights
+Added: (b) Number of Securities Remaining Available for Future Issuance Under Equity Compensation Plans (excluding securities reflected in column (a))
Equity compensation plans approved by security holders 4,872,800 $ 5.48 2,351,369
Equity compensation plans not approved by security holders (1)
+Added: 66,143 $ 4.05 —
+Added: Total 4,938,943 $ 5.46 2,351,369
(1) Represents inducement grants for new hires
6 unchanged sentences
The line graph assumes, in each case, an initial investment of $100 on December 31, 2016, based on the market prices at the end of each fiscal year through and including December 31, 2020, and reinvestment of dividends.
+Added: 2016 2017 2018 2019 2020
Apyx Medical Corporation 100.00 72.42 180.49 235.64 200.54
3 unchanged sentences
Selected Financial Data
−Removed: The following selected consolidated financial data (presented in thousands, except per share amounts and employee data) are derived from our consolidated financial statements.
−Removed: On August 30 th , 2018, we sold our Core business segment and discontinued those operations.
−Removed: All the information in this table has been restated to reflect this disposition.
−Removed: This data should be read in conjunction with the consolidated financial statements and notes thereto and with Item 7.
−Removed: Management’s Discussion and Analysis of Financial Condition and Results of Operations.
−Removed: 2018 as Restated
−Removed: Cost of sales
−Removed: Other costs and expenses:
−Removed: Research and development
−Removed: Professional services
−Removed: Salaries and related costs
−Removed: Selling, general and administrative
−Removed: Severance and related expense
−Removed: Total other costs and expenses
−Removed: Loss from operations
−Removed: Interest income
−Removed: Interest expense
−Removed: Other losses, net
−Removed: Change in fair value of derivative liabilities
−Removed: Total other income, net
−Removed: Loss before income taxes
−Removed: Income tax benefit
−Removed: Net loss from continuing operations
−Removed: Income from discontinued operations, net of tax
−Removed: Gain on sale of the Core Business, net of tax
−Removed: Income from discontinued operations, net of tax
−Removed: Net income (loss)
−Removed: Balance Sheet Information:
−Removed: Total current assets
−Removed: Short term investments
−Removed: Working Capital
−Removed: Long Term Liabilities
−Removed: Total Stockholder's Equity
+Added: Not Required.
APYX MEDICAL CORPORATION
−Removed: MANAGEMENT'S DISCUSSION AND ANAYLSIS OF
+Added: MANAGEMENT'S DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF OPERATIONS
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.